OncoSignal
← Childhood acute lymphoblastic leukemia investigators

Kara Davis

Stanford University

Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.

Registry trials as an overall official
2
all conditions, ClinicalTrials.gov
NIH grants tied to them
3
NIH RePORTER
Trial papers in childhood acute lymphoblastic leukemia
5
PubMed author-name match

Trials

Studies that name Kara Davis as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:29 UTC. Open this list on ClinicalTrials.gov

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:29 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

Most cited trial papers

Clinical-trial papers with this author name in childhood acute lymphoblastic leukemia, ranked by citations from NIH iCite, fetched 2026-11-12 11:29 UTC. The ranking covers the 200 most relevant of 5 PubMed records, and a shared surname and initials can bring in a namesake. All 5 on PubMed

  1. 4,679 citations
    RCR 163.2
  2. 345 citations
    RCR 28.7
  3. 84 citations
    RCR 3.0
  4. 50 citations
    RCR 5.3
  5. 0 citations